Orexo AB (publ) - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ORXOY Over the counter 2830 www.orexo.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Orexo AB (publ)

Orexo AB (ORXOY) Q2 2026 Earnings Call Highlights: Strategic Advances Amidst Legal and ... - Jul 16th, 2026 1:00 pm
Orexo announces positive outcome from an in-vivo study of OX390 - May 19th, 2026 7:06 am
Orexo AB (ORXOF) Q1 2026 Earnings Call Highlights: Strategic Divestment and R&D Investments ... - Apr 29th, 2026 9:00 am
Orexo AB (ORXOF) Q4 2025 Earnings Call Highlights: Strategic Divestment and Financial Resilience - Feb 9th, 2026 6:04 pm
Dexcel Pharma USA Acquires US Rights to Zubsolv® - Jan 7th, 2026 2:34 pm
Q&A with Robert DeLuca, President of Orexo US, Inc. | OTC Nordic Investor Day 2025 - Oct 31st, 2025 2:38 am
Orexo (OM:ORX) Remains Unprofitable as Losses Persist Despite 5.6% Revenue Growth Outlook - Oct 23rd, 2025 9:23 pm
Is it Time for Investors to Look North for Growth? - Sep 18th, 2025 5:03 am
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication - Sep 5th, 2025 6:31 am
Seminar: IP That Matters - Behind Orexo's Milestone Patent Win at the US Court - Aug 29th, 2025 6:14 am